|
1
|
Torimoto K, Okada Y, Nakayamada S, Kubo S
and Tanaka Y: Anti-PD-1 antibody therapy induces Hashimoto's
disease with an increase in peripheral blood follicular helper T
cells. Thyroid. 27:1335–1336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zaletel K and Gaberšček S: Hashimoto's
thyroiditis: From genes to the disease. Curr Genomics. 12:576–588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sendt W, Rippe V, Flor I, Drieschner N and
Bullerdiek J: Monosomy and ring chromosome 13 in a thyroid nodular
goiter - do we underestimate its relevance in benign thyroid
lesions? Cancer Genet. 205:128–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song E, Jeon MJ, Park S, Kim M, Oh HS,
Song DE, Kim WG, Kim WB, Shong YK and Kim TY: Influence of
coexistent Hashimoto's thyroiditis on the extent of cervical lymph
node dissection and prognosis in papillary thyroid carcinoma. Clin
Endocrinol (Oxf). 88:123–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wells SA Jr, Asa SL, Dralle H, Elisei R,
Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, et al:
American Thyroid Association Guidelines Task Force on Medullary
Thyroid Carcinoma: Revised American Thyroid Association guidelines
for the management of medullary thyroid carcinoma. Thyroid.
25:567–610. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao J, Xu C, Yao J, Yu C, Liao L and Dong
J: Statins and thyroid carcinoma: A meta-analysis. Cell Physiol
Biochem. 47:1422–1431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fallahi P, Ferrari SM, Camastra S, Politti
U, Ruffilli I, Vita R, Navarra G, Benvenga S and Antonelli A: TSH
normalization in bariatric surgery patients after the switch from
L-thyroxine in tablet to an oral liquid formulation. Obes Surg.
27:78–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu ZG, Yan XQ, Su RS, Ma ZS, Xie BJ and
Cao FL: How many contralateral carcinomas in patients with
unilateral papillary thyroid microcarcinoma are preoperatively
misdiagnosed as benign? World J Surg. 41:129–135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trzybulska D, Bobjer J, Giwercman A and
Tsatsanis C: Serum microRNAs in male subfertility-biomarkers and a
potential pathogenetic link to metabolic syndrome. J Assist Reprod
Genet. 34:1277–1282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasinski AL, Kelnar K, Stahlhut C,
Orellana E, Zhao J, Shimer E, Dysart S, Chen X, Bader AG and Slack
FJ: A combinatorial microRNA therapeutics approach to suppressing
non-small cell lung cancer. Oncogene. 34:3547–3555. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lima CR, Geraldo MV, Fuziwara CS, Kimura
ET and Santos MF: MiRNA-146b-5p upregulates migration and invasion
of different papillary thyroid carcinoma cells. BMC Cancer.
16:1082016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kagawa T, Watanabe M, Inoue N, Otsu H,
Saeki M, Katsumata Y, Takuse Y and Iwatani Y: Increases of microRNA
let-7e in peripheral blood mononuclear cells in Hashimoto's
disease. Endocr J. 63:375–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Girardi FM, Barra MB and Zettler CG:
Papillary thyroid carcinoma: Does the association with Hashimoto's
thyroiditis affect the clinicopathological characteristics of the
disease? Braz J Otorhinolaryngol. 81:283–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lang BH, Shek TW, Chan AO, Lo CY and Wan
KY: Significance of size of persistent/recurrent central nodal
disease on surgical morbidity and response to therapy in
reoperative neck dissection for papillary thyroid carcinoma.
Thyroid. 27:67–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Z, Zhang Y, Feng D, Sheng J, Yang W and
Liu B: Targeted next generation sequencing identifies somatic
mutations and gene fusions in papillary thyroid carcinoma.
Oncotarget. 8:45784–45792. 2017.PubMed/NCBI
|
|
18
|
Hay ID, Johnson TR, Thompson GB, Sebo TJ
and Reinalda MS: Minimal extrathyroid extension in papillary
thyroid carcinoma does not result in increased rates of either
cause-specific mortality or postoperative tumor recurrence.
Surgery. 159:11–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hill M and Tran N: MicroRNAs regulating
microRNAs in cancer. Trends Cancer. 4:465–468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakasa T, Miyaki S, Okubo A, Hashimoto M,
Nishida K, Ochi M and Asahara H: Expression of microRNA-146 in
rheumatoid arthritis synovial tissue. Arthritis Rheum.
58:1284–1292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chou CK, Chi SY, Huang CH, Chou FF, Huang
CC, Liu RT and Kang HY: IRAK1, a target of miR-146b, reduces cell
aggressiveness of human papillary thyroid carcinoma. J Clin
Endocrinol Metab. 101:4357–4366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou CK, Yang KD, Chou FF, Huang CC, Lan
YW, Lee YF, Kang HY and Liu RT: Prognostic implications of miR-146b
expression and its functional role in papillary thyroid carcinoma.
J Clin Endocrinol Metab. 98:E196–E205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun M, Fang S, Li W, Li C, Wang L, Wang F
and Wang Y: Associations of miR-146a and miR-146b expression and
clinical characteristics in papillary thyroid carcinoma. Cancer
Biomark. 15:33–40. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YS, Lim YS, Lee JC, Wang SG, Park HY,
Kim SY and Lee BJ: Differential expression levels of plasma-derived
miR-146b and miR-155 in papillary thyroid cancer. Oral Oncol.
51:77–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
